Document Detail


Brain MRI with single-dose (0.1 mmol/kg) Gadobutrol at 1.5 T and 3 T: comparison with 0.15 mmol/kg Gadoterate meglumine.
MedLine Citation:
PMID:  20410423     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: The purpose of this article is to evaluate the efficacy of a single dose of gadobutrol (0.1 mmol/kg of body weight) compared with that of a substantially higher dose of gadoterate meglumine (0.15 mmol/kg of body weight) in a rat brain tumor model at 1.5 and 3 T. MATERIALS AND METHODS: A cohort of 20 Fischer rats with a surgically implanted plastic brain cannula for glioma cell injection was divided into two groups. Group A underwent MRI at 1.5 T, and group B underwent MRI at 3 T. All rats were implanted with 10 microL of C6/lacZ glioma cells. Seven days after tumor cell implantation, MRI was performed with the first of two contrast agents in randomized order. Twenty-four hours later, MRI was performed with the second contrast agent. Both contrast agents were macrocyclic but differed in concentration. All rats were sacrificed after the second MRI scan was obtained, and brains were harvested for histopathologic assessment. For evaluation of image quality, signal-to-noise ratio, contrast-to-noise ratio, and lesion enhancement were evaluated. RESULTS: Two rats in each group died before the imaging protocol was completed. Thus, 16 rats could be evaluated. At both 1.5 and 3 T, no significant differences between the two contrast agents were found in terms of signal-to-noise ratio, contrast-to-noise ratio, and lesion enhancement, although the contrast agents were applied at substantially different dosages. CONCLUSION: The amount of gadobutrol needed to reach the same efficacy as gadoterate meglumine is substantially lower, which may be beneficial for patients with impaired renal function. In addition, increasing the dose of gadobutrol to 0.15 mmol/kg of body weight can potentially lead to better delineation of lesions.
Authors:
Harald Kramer; Val M Runge; L Gill Naul; Alan T Loynachan; Maximilian F Reiser; Bernd J Wintersperger
Related Documents :
18082973 - Acute induction of epileptiform discharges by pilocarpine in the in vitro isolated guin...
2912763 - The uptake of [14c]deoxyglucose into brain of young rats with inherited hydrocephalus.
12695743 - Pathophysiology of disseminated intravascular coagulation (dic) progresses at a differe...
Publication Detail:
Type:  Comparative Study; Evaluation Studies; Journal Article    
Journal Detail:
Title:  AJR. American journal of roentgenology     Volume:  194     ISSN:  1546-3141     ISO Abbreviation:  AJR Am J Roentgenol     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-04-22     Completed Date:  2010-05-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7708173     Medline TA:  AJR Am J Roentgenol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1337-42     Citation Subset:  AIM; IM    
Affiliation:
Department of Clinical Radiology, University Hospitals Munich, Grosshadern Campus, Marchioninistrasse 15, Munich 81377, Germany. harald.kramer@med.lmu.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Brain / pathology*
Brain Neoplasms / pathology*
Contrast Media / administration & dosage
Dose-Response Relationship, Drug
Female
Glioma / pathology*
Magnetic Resonance Imaging / methods*
Male
Meglumine / administration & dosage,  therapeutic use*
Organometallic Compounds / administration & dosage,  diagnostic use*,  therapeutic use*
Rats
Rats, Inbred F344
Reproducibility of Results
Sensitivity and Specificity
Chemical
Reg. No./Substance:
0/Contrast Media; 0/Organometallic Compounds; 0/gadoterate meglumine; 138071-82-6/gadobutrol; 6284-40-8/Meglumine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Arterial input function placement for accurate CT perfusion map construction in acute stroke.
Next Document:  Perceptibility and quantification of in-stent stenosis with six peripheral arterial stent types in v...